Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The gradual loss of DNA from the ends of telomeres has been implicated in the control of cellular proliferative potential. Telomerase is an enzyme that restores telomeric DNA sequences, and expression of its activity was thought to be essential for the immortalization of human cells, both in vitro and in tumor progression in vivo. Telomerase activity has been detected in 50-100% of tumors of different types, but not in most normal adult somatic tissues. It has also been detected in about 70% of human cell lines immortalized in vitro and in all tumor-derived cell lines examined to date. It has previously been shown that in vitro immortalized telomerase-negative cell lines acquire very long and heterogeneous telomeres in association with immortalization presumably via one or more novel telomere-lengthening mechanisms that we refer to as ALT (alternative lengthening of telomeres). Here we report evidence for the presence of ALT in a subset of tumor-derived cell lines and tumors. The maintenance of telomeres by a mechanism other than telomerase, even in a minority of cancers, has major implications for therapeutic uses of telomerase inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a few rare tumors (29) and some experimentally immortalized cell lines (30) lack detectable telomerase activity.”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [30]
In the citing paper
“Virally transformed human cells that eliminate p53 and/or pRB function can escape crisis at very low frequencies, and invariably adopt telomere-maintenance programs: 80-90% of human tumors possess some telomerase activity, while the remainder maintain telomeres via a recombination-mediated process termed ALT (for Alternative Lengthening of Telomeres)37-40.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [39]
In the citing paper
“A significant number of human tumours can also maintain telomeres by recombination-based ALT mechanisms in the absence of telomerase 72 .”
From The common biology of cancer and ageing (2007) · cites this paper as [72]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
Telomere elongation in immortal human cells without detectable telomerase activity
Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S., & Reddel, R. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00098.x · Cited by 1,279
Self-citationTelomere loss: mitotic clock or genetic time bomb?
Harley, C. B. (1991) · Mutation Research/DNAging · doi:10.1016/0921-8734(91)90018-7 · Cited by 1,139
An alternative pathway for yeast telomere maintenance rescues est1− senescence
Lundblad, V., & Blackburn, E. H. (1993) · Cell · doi:10.1016/0092-8674(93)90234-h · Cited by 942
Telomerase activity in human ovarian carcinoma.
Counter, C. M., Hirte, H. W., Bacchetti, S., & Harley, C. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.2900 · Cited by 677
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 660
[Principle of marginotomy in template synthesis of polynucleotides].
Olovnikov, A. M. (1971) · PubMed · Cited by 563
Härle-Bachor, C., & Boukamp, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6476 · Cited by 498
Wright, W. E., Shay, J. W., & Piatyszek, M. A. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.18.3794 · Cited by 475
Telomerase Activity in Small-Cell and Non-Small-Cell Lung Cancers
Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., & Shay, J. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.12.895 · Cited by 440
Telomerase Activity in Human Breast Tumors
Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., & Shay, J. W. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.2.116 · Cited by 423
Piatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E., & Shay, J. W. (1995) · Methods in Cell Science · doi:10.1007/bf00981880 · Cited by 384
Telomere dynamics in an immortal human cell line.
Murnane, J. P., Sabatier, L., Marder, B. A., & Morgan, W. F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06822.x · Cited by 381
Telomerase activity associated with acquisition of malignancy in human colorectal cancer.
Chadéneau, C., Hay, K. D., Hirte, H. W., Gallinger, S., & Bacchetti, S. (1995) · PubMed · Cited by 357
Detection of Telomerase Activity in Malignant and Nonmalignant Skin Conditions
Stan Taylor, R., Ramirez, R. D., Ogoshi, M., Chaffins, M., Piatyszek, M. A., & Shay, J. W. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12345811 · Cited by 267
Kyrion, G., Boakye, K. A., & Lustig, A. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5159 · Cited by 250
Rogan, E. M., Bryan, T. M., Hukku, B., Maclean, K., Chang, A. C.-M., Moy, E. L., Englezou, A., Warneford, S. G., Dalla-Pozza, L., & Reddel, R. R. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4745 · Cited by 250
Self-citationTelomerase activity in normal human epithelial cells.
Yasumoto, S., Kunimura, C., Kikuchi, K., Tahara, H., Ohji, H., Yamamoto, H., Ide, T., & Utakoji, T. (1996) · PubMed · Cited by 247
McEachern, M. J., & Blackburn, E. H. (1996) · Genes & Development · doi:10.1101/gad.10.14.1822 · Cited by 224
Telomere dynamics and telomerase activity in in vitro immortalised human cells
Bryan, T. M., & Reddel, R. R. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00065-8 · Cited by 222
Self-citationTelomerase activity in human intestine
Hiyama, E., Tatsumoto, N., Kodama, T., Hiyama, K., Shay, J., & Yokoyama, T. (1996) · International Journal of Oncology · doi:10.3892/ijo.9.3.453 · Cited by 203
Control of telomere growth by interactions of RAP1 with the most distal telomeric repeats
Krauskopf, A., & Blackburn, E. H. (1996) · Nature · doi:10.1038/383354a0 · Cited by 151
Sugino, T., Yoshida, K., Bolodeoku, J., Tahara, H., Buley, I., Manek, S., Wells, C., Goodison, S., Ide, T., Suzuki, T., et al. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960822)69:4<301::aid-ijc11>3.0.co;2-8 · Cited by 115
Hiyama, E., Hiyama, K., Yokoyama, T., Ichikawa, T., & Matsuura, Y. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb00081.x · Cited by 104
TELOMERES AND TELOMERASE IN HUMAN CANCER (REVIEW)
BACCHETTI, S., & COUNTER, C. (1995) · International Journal of Oncology · doi:10.3892/ijo.7.3.423 · Cited by 104
Telomerase activity in human renal cell carcinoma.
Mehle, C., Piatyszek, M. A., Ljungberg, B., Shay, J. W., & Roos, G. (1996) · PubMed · Cited by 90
Telomerase activity in normal human endothelial cells.
Hsiao, R., Sharma, H. W., Ramakrishnan, S., Keith, E., & Narayanan, R. (1997) · PubMed · Cited by 89
Development of Retinoblastoma in the Absence of Telomerase Activity
Gupta, J., Han, L.-P., Wang, P., Gallie, B. L., & Bacchetti, S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1152 · Cited by 74
Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cells.
Whitaker, N. J., Bryan, T. M., Bonnefin, P., Chang, A. C.-M., Musgrove, E. A., Braithwaite, A. W., & Reddel, R. R. (1995) · PubMed · Cited by 73
Self-citationAssociation of extended in vitro proliferative potential with loss of p16INK4 expression.
Noble, J. R., Rogan, E. M., Neumann, A. A., MacLean, K. H., Bryan, T. M., & Reddel, R. R. (1996) · PubMed · Cited by 64
Self-citationAssignment of SV40-Immortalized Cells to More Than One Complementation Group for Immortalization
Duncan, E. L., Whitaker, N. J., Moy, E. L., & Reddel, R. R. (1993) · Experimental Cell Research · doi:10.1006/excr.1993.1095 · Cited by 52
Self-citationChanges of telomere lengths in human intracranial tumours
N�rnberg, P., Thiel, G., Weber, F., & Epplen, J. T. (1993) · Human Genetics · doi:10.1007/bf00222724 · Cited by 51
Germ-line splicing mutation of the p53 gene in a cancer-prone family.
Warneford, S., Witton, L. J., Townsend, M., Rowe, P. B., Reddel, R. R., Dalla‐Pozza, L., & Symonds, G. P. (1992) · PubMed · Cited by 46
Self-citationNormal telomere maintenance in immortal ataxia telangiectasia cell lines
Sprung, C. N., Bryan, T. M., Reddel, R. R., & Murnane, J. P. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00119-x · Cited by 34
Self-citation
Cited by
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
“or to invention of alternative mechanisms that can solve the telomere proble”
BackgroundMammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447
“…Rockefeller University at human chromosome ends, either by telomeraseNew York, New York 10021 (Bodnar et al., 1998) or an alternative mechanism (ALT; Bryan et al., 1997), is essential for long-term replicative survival of cells in vitro, and a telomerase-deficientSummary mouse strain displays…”
BackgroundThe hallmarks of cancer: A long non-coding RNA point of view
Gutschner, T., & Diederichs, S. (2012) · RNA Biology · doi:10.4161/rna.20481 · Cited by 1,802
How Shelterin Protects Mammalian Telomeres
Palm, W., & de Lange, T. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130350 · Cited by 1,802
“Telomeres of polytene chromosomes in a ciliated protozoan terminate in duplex DNA loops.”
BackgroundInfluentialWhole-genome landscapes of major melanoma subtypes
Hayward, N. K., Wilmott, J. S., Waddell, N., Johansson, P. A., Field, M. A., Nones, K., Patch, A.-M., Kakavand, H., Alexandrov, L. B., Burke, H., et al. (2017) · Nature · doi:10.1038/nature22071 · Cited by 1,461
“Finally, we show the highly prevalent TERT promoter mutations in melanoma must confer selective advantage via dysregulation of telomere protection, whether via telomerase or the ALT mechanism, since they result in reduced, not increased telomere length.”
Metadata
- Authors
- Bryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A., & Reddel, R. R.
- Affiliations
- Children's Medical Research Institute (AU)
- Corresponding author
- Reddel, Roger R.
- Venue
- Nature Medicine
- Published
- 1997-11
- Volume
- 3
- Issue
- 11
- Pages
- 1271-1274
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2013073993
- Cited by
- 1,292
- References
- 39
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 37 · 2023: 48 · 2022: 31 · 2021: 34 · 2020: 44 · 2019: 52 · 2018: 27 · 2017: 54 · 2016: 35 · 2015: 52 · 2014: 33 · 2013: 52 · 2012: 39
- FWCI
- 27.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- alternative lengthening of telomeres, telomere maintenance, telomerase, tumor-derived cell lines, cell immortalization, telomerase inhibitors, cancer therapy, telomere loss
- MeSH terms
- Adult, DNA Nucleotidyltransferases, Humans, Neoplasms, Tumor Cells, Cultured, Deoxyribonucleases, Type II Site-Specific, Telomere, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.